Species Distribution and Antifungal Susceptibilities of Yeast Clinical Isolates from Three Hospitals in Korea, 2001 to 2007.
10.3343/kjlm.2010.30.4.364
- Author:
Mi Kyung LEE
1
;
Dongeun YONG
;
Myungsook KIM
;
Mi Na KIM
;
Kyungwon LEE
Author Information
1. Department of Laboratory Medicine, Chung-Ang University College of Medicine, Seoul, Korea. cpworld@cau.ac.kr
- Publication Type:Original Article ; English Abstract
- Keywords:
Yeast;
Fluconazole;
Voriconazole;
Surveillance
- MeSH:
Antifungal Agents/*pharmacology;
Candida/isolation & purification;
Cryptococcus neoformans/isolation & purification;
Disk Diffusion Antimicrobial Tests;
*Drug Resistance, Fungal;
Fluconazole/pharmacology;
Hospitals;
Humans;
Pyrimidines/pharmacology;
Republic of Korea;
Rhodotorula/isolation & purification;
Triazoles/pharmacology;
Trichosporon/isolation & purification;
Yeasts/*drug effects/isolation & purification
- From:The Korean Journal of Laboratory Medicine
2010;30(4):364-372
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: We utilized results from the ARTEMIS DISK Global Antifungal Surveillance Program to evaluate the species distribution and fluconazole and voriconazole susceptibilities of yeast isolates from clinical specimens in South Korea from 2001 to 2007. METHODS: Data were collected on 5,665 yeast isolates from all body sites at three locations. All investigators tested clinical yeast isolates using the CLSI M44-A disk diffusion method. Test plates were automatically read and results were recorded using the BIOMIC image analysis plate reader system (Giles Scientific, USA). Species, drug, zone diameter, susceptibility category, and quality control results were collected quarterly via e-mail for analysis. RESULTS: Candida albicans was the most common isolate, but a progressive increase in non-C. albicans Candida and noncandidal yeast species has been observed in recent years. The overall percentages of isolates in each category (susceptible, susceptible dose dependent, and resistant) were 98.8%, 0.5%, and 0.7% and 99.2%, 0.2%, and 0.6% for fluconazole and voriconazole, respectively. Candida of 3 species exhibited decreased susceptibility to fluconazole (<90% S) in the order of that seen with the resistant (R) species: C. krusei, C. guilliermondii, and C. glabrata. Emerging resistance to fluconazole or voriconazole was documented among isolates of Cryptococcus neoformans, Trichosporon spp., and Rhodotorula spp. CONCLUSIONS: The species distribution and antifungal susceptibilities of yeasts may differ according to specimen type, testing method, hospital, and geographic region. Therefore, further large-scaled, long-term surveillance studies are needed to isolate yeasts and to confirm the species distribution and antifungal susceptibilities of yeast isolates from clinical specimens in Korea.
